Table 1.

Minimal inhibitory concentrations (MICs µg/mL) for the patient’s isolates of Efm as reported by the clinical microbiology laboratory.

Antibacterial	Isolate 1 (VRE)	Isolate 2 (LVRE)	Isolate 3a (DLVRE)	Isolate 4a (DLVRE)	Isolate 5a (DLVRE)
Source	Peritoneal Fluid	Abdominal Fluid	Blood & PICC	LLQ Abdominal Wall	Abdominal Abscess
Ampicillin	≥ 32 Rb	≥ 32 Rb	≥ 32 Rb	≥ 32 Rb	≥ 32 Rb
Daptomycin	–	2 Sc	12 Rc	16 Rc	4 Sc
Linezolid	2 Sb	128 Rc	≥ 256 Rc	≥ 8 Rb	2 Sb
Ciprofloxacin	≥ 8 Rb	≥ 8 Rb	≥ 8 Rb	≥ 8 Rb	≥ 8 Rb
Levofloxacin	≥ 8 Rb	≥ 8 Rb	≥ 8 Rb	≥ 8 Rb	≥ 8 Rb
Erythromycin	≥ 8 Rb	≥ 8 Rb	≥ 8 Rb	4 Ib	≥ 8 Rb
Gentamicin (synergy)	SYN-Sb	SYN-Sb	SYN-Sb	SYN-Sb	SYN-Sb
Streptomycin (synergy)	SYN-Sb	SYN-Sb	SYN-Sb	SYN-Sb	SYN-Sb
Nitrofurantoin	64 Ib	64 Ib	64 Ib	32 Sb	64 Ib
Tetracycline	≥ 16 Rb	≥ 16 Rb	≥ 16 Rb	≥ 16 Rb	≥ 16 Rb
Tigecycline	≤ 0.12 Sb	≤ 0.12 Sb	≤ 0.12 Sb	≤ 0.12 Sb	≤ 0.12 Sb
			0.094 NIc		0.125 NIc
Vancomycin	≥ 32 Rb	≥ 32 Rb	≥ 32 Rb	≥ 32 Rb	≥ 32 Rb
Ceftaroline			32 NIc

R, resistant; S, susceptible; I, intermediate, NI, no interpretation; –, not reported.

^aSequenced isolate.

^bMICs determined by Vitek-2 AST GP75.

^cMICs determined by MIC strip testing assays.